@FiercePharma: Scientists roll out innovative health-tracking device for guide dogs. FierceAnimalHealth story | Follow @FiercePharma
@EricPFierce: ICYMI: FDA warning letter says Dr Reddy's hid existence of QC testing lab where retesting was done. Report | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: Trump, Clinton lash out at Pfizer over Allergan deal agreement. Article | Follow @CarlyHFierce
> Pfizer ($PFE) has won a label expansion in the EU for Xalkori as a first-line treatment for adults with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC). Release
> Pfizer's blockbuster pain drug, Lyrica failed to show benefit in patients suffering from a type of post-traumatic neuropathic pain, for which there is no approved drug in the U.S. Story
> Daiichi Sankyo is teaming up with Sanofi's ($SNY) Japanese unit to launch Squarekids, a DPT-polio vaccine, in Japan. Story
> The FDA has approved Eli Lilly's ($LLY) Portrazza to treat advanced squamous non-small cell lung cancer. Release
> Mylan has launched Clozapine orally disintegrating tablets--a generic of Jazz Pharmaceutical's ($JAZZ) FazaClo--in the U.S. Release
Medical Device News
@FierceMedDev: Cigna rolls out new coverage policy for whole exome sequencing. Article | Follow @FierceMedDev
@VarunSaxena2: ICYMI from FierceDrugDelivery: Physicians call for novel abuse-deterrent opioid agonist/antagonist formulations in survey. Story | Follow @VarunSaxena2
@EmilyWFierce: Scientists roll out innovative health-tracking device for guide dogs. FierceAnimalHealth story | Follow @EmilyWFierce
> Entellus wins FDA clearance for its endoscope to treat blocked sinus passages. More
> Alphabet gives startups a lesson in financial management. Article
Biotech News
@FierceBiotech: FierceBiotech Radio on the ins and outs of 'Pfizergan' and whatever it is Martin Shkreli's doing. More | Follow @FierceBiotech
@JohnCFierce: Any journos who would like to attend our #JPM16 breakfast event on Big Data? Drop me a line @ [email protected]. More info | Follow @JohnCFierce
> Novo Nordisk taps Ablynx in a $400M deal. Item
> Allergan scoops up some CNS drugs as its $160B Pfizer merger pends. More
Pharma Marketing News
> Meda breaks down asthma with Medikidz comic book series for children. Report
> Kantar Media survey: Not all docs hate all ads. Article
> Turing sidesteps list-price discount on jacked-up therapy Daraprim. Item
> Purple haze: Dr. Reddy's strikes back at AstraZeneca in Nexium court battle. Story
> If TV's everywhere, then where does pharma need to be? More
Biotech Research News
> Sanford Burnham team sees promise in new melanoma drug. More
> Fruit flies may provide a biomarker for early-onset Parkinson's. Item
> U.K. investigators publish small, promising study of Victoza for NASH. Report
> Arno's HDAC inhibitor looks promising in preclinical cachexia study as cash runs low. Story
> Mount Sinai team maps a key combo role for new checkpoint drugs. Article
Vaccines News
> Daiichi Sankyo, Sanofi to launch DPT-polio vaccine in Japan. News
> Vaxart's oral RSV candidate protects in preclinical challenge. Report
> SUNY Upstate Medical University, U.S. Army start $12M partnership toward dengue vaccine. More
> FDA expands indication of Emergent BioSolutions anthrax vaccine. Article
> Celldex's brain cancer vaccine Rintega shows survival advantage at 2-year mark. Story
And Finally... The FDA has expanded the indication of Emergent BioSolutions ($EBS) anthrax vaccine, BioThrax, for use in adults aged 18 to 65 in conjunction with antibiotic treatment, following confirmed or suspected exposure. Story